USANA Health Sciences (USNA) Reaches New 52-Week High and Low at $97.63

USANA Health Sciences, Inc. (NYSE:USNA)’s share price reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $97.63 and last traded at $97.30, with a volume of 68730 shares trading hands. The stock had previously closed at $96.90.

Several research firms have recently issued reports on USNA. Pivotal Research raised their price target on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. TheStreet downgraded shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research note on Tuesday, February 6th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.

The company has a market cap of $2,299.12, a PE ratio of 23.78 and a beta of 0.82.



USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.11. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.08%. The business had revenue of $273.11 million during the quarter, compared to the consensus estimate of $258.67 million. During the same quarter last year, the firm earned $0.87 earnings per share. USANA Health Sciences’s quarterly revenue was up 8.0% on a year-over-year basis. equities research analysts predict that USANA Health Sciences, Inc. will post 4.25 EPS for the current year.

In related news, Director Myron W. Wentz sold 38,223 shares of USANA Health Sciences stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $71.51, for a total transaction of $2,733,326.73. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Global Ltd Gull sold 8,344 shares of USANA Health Sciences stock in a transaction on Monday, February 5th. The stock was sold at an average price of $72.28, for a total transaction of $603,104.32. Following the transaction, the insider now directly owns 11,682,053 shares of the company’s stock, valued at approximately $844,378,790.84. The disclosure for this sale can be found here. Insiders have sold 729,767 shares of company stock valued at $58,024,833 in the last three months. 53.20% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in USNA. Allianz Asset Management GmbH increased its stake in USANA Health Sciences by 8.8% in the third quarter. Allianz Asset Management GmbH now owns 11,425 shares of the company’s stock valued at $659,000 after purchasing an additional 920 shares in the last quarter. JPMorgan Chase & Co. increased its stake in USANA Health Sciences by 6.4% in the third quarter. JPMorgan Chase & Co. now owns 17,440 shares of the company’s stock valued at $1,005,000 after purchasing an additional 1,055 shares in the last quarter. New York State Common Retirement Fund increased its stake in USANA Health Sciences by 5.2% in the third quarter. New York State Common Retirement Fund now owns 34,226 shares of the company’s stock valued at $1,975,000 after purchasing an additional 1,692 shares in the last quarter. Swiss National Bank increased its stake in USANA Health Sciences by 10.1% in the fourth quarter. Swiss National Bank now owns 19,600 shares of the company’s stock valued at $1,451,000 after purchasing an additional 1,800 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in USANA Health Sciences by 2.2% in the third quarter. Bank of New York Mellon Corp now owns 92,137 shares of the company’s stock valued at $5,317,000 after purchasing an additional 1,944 shares in the last quarter. 48.28% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “USANA Health Sciences (USNA) Reaches New 52-Week High and Low at $97.63” was published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://dakotafinancialnews.com/2018/04/12/usana-health-sciences-usna-reaches-new-52-week-high-and-low-at-97-63.html.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply